Search for: "Tom Lamb"
Results 721 - 740
of 1,047
Sorted by Relevance
|
Sort by Date
10 Oct 2016, 12:40 pm
(Case review done by attorney Tom Lamb) [read post]
12 Mar 2020, 2:17 pm
(Case review is done by attorney Tom Lamb) [read post]
1 Mar 2023, 12:53 pm
(Case review is done by attorney Tom Lamb) [read post]
9 Aug 2023, 10:55 am
(Attorney Tom Lamb does all case reviews) [read post]
7 Aug 2020, 12:03 pm
(Case review is done by attorney Tom Lamb) [read post]
16 Dec 2008, 11:04 pm
Related Recall Of Over-The-Counter OSP Fleet Phospho-Soda, Which Is Subject Of Product Liability Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) On December 11, 2008 the FDA issued by email a MedWatch Safety Alert which was titled "Oral Sodium Phosphate (OSP) Products for Bowel Cleansing: reports of acute phosphate nephropathy, Boxed Warning to be added to labeling". [read post]
28 Jun 2009, 6:17 pm
(Posted by Tom Lamb at DrugInjuryWatch.com) On June 26, 2009 we learned from a Blooomberg news report, "Roche Pulls Accutane Off Market After Jury Verdicts", that Accutane will no longer be available to American patients: Roche Holding AG, the world's biggest maker of cancer drugs, is pulling its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. [read post]
12 Nov 2008, 5:14 pm
(Posted by Tom Lamb at DrugInjuryWatch.com) In late April 2008, when the Digitek recall was announced by Actavis, most were surprised to hear that so-called "double-dose" pills were being produced by a drug company here in the U.S. [read post]
24 Apr 2009, 1:04 pm
Don't Be Afraid To Talk With Your Doctor About Any Medication You Are Prescribed -- Especially If The Drug Is Being Used As A Treatment NOT Approved By FDA (Posted by Tom Lamb at DrugInjuryWatch.com) Let's start with an informal and short definition of so-called "off-label" prescribing: A drug is being prescribed "off-label" when it has not been approved for treatment of the patient's medical condition and, instead, is being used experimentally.… [read post]
30 Jul 2009, 7:02 am
Judge Keenan Denies Merck's Summary Judgment Motion, But Rules That Merck Will Not Face Possible Punitive Damages In This Case Involving Shirley Boles (Posted by Tom Lamb at DrugInjuryWatch.com) According to a July 29, 2009 Bloomberg article, "Merck Won't Face Punitive Damages in Fosamax Trial": U.S. [read post]
30 Oct 2008, 5:41 pm
October 2008 Public Citizen Petition Wants Glaxo's Diabetes Drug Banned Due To "New" Side Effect, Liver Toxicity (Posted by Tom Lamb at DrugInjuryWatch.com) On October 30, 2008 Public Citizen's Health Research Group (HRG) submitted a petition to the FDA requesting that GlaxoSmithKline's diabetes drug Avandia (rosiglitazone) be banned due to the drug's several serious side effects, including some newly found cases of liver failure. [read post]
24 Mar 2008, 1:03 pm
Eli Lilly Trial: Focus Is On What Was Known About This Alleged Side Effect, And When They Knew It (Posted by Tom Lamb at DrugInjuryWatch.com) News reports about the case Alaska v. [read post]
9 Jun 2009, 1:27 pm
Whether Avandia Causes Heart Attacks Remains An Open Issue, Despite Recent RECORD Study Results (Posted by Tom Lamb at DrugInjuryWatch.com) On June 5, 2009, at the annual meeting of the American Diabetes Association (ADA) in New Orleans, GlaxoSmithKline announced the results of a much-anticipated study regarding its diabetes drug Avandia (rosiglitazone). [read post]
22 Jul 2008, 3:10 pm
Beware If Taking This Seizure Medicine Alone Or With Other Epilepsy Drugs During Pregnancy (Posted by Tom Lamb at DrugInjuryWatch.com) The July 22, 2008 issue of Neurology, the medical journal of the American Academy of Neurology (AAN), includes an article which reports taking the epilepsy drug Topamax (topiramate) alone or along with other epilepsy drugs during pregnancy may increase the risk of birth defects. [read post]
1 Nov 2007, 8:20 am
October 2007 FDA Letter Says Aventis Did Not Follow Regulations And Statutory Requirements; Company Contends Study Conducted In Good Faith (Posted by Tom Lamb at DrugInjuryWatch.com) On October 24, 2007 the FDA posted on its web site a copy of an 11-page "Warning Letter" to Sanofi-Aventis (SNY) about problems with Ketek Study 3014. [read post]
15 Jul 2008, 4:33 pm
In Wake of "Double-Dose" Digitek Pills And ETHEX Morphine Tablets Being Recalled, Drugmaker Ranbaxy Faces Allegations About Fake Data As Regards Quality Of Its Generic Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) A July 15, 2008 article, "Ranbaxy denies any misconduct", published by The Star-Ledger put scrutiny on one generic drug manufacturer and raises the concern, more generally, that the FDA has not been monitoring the quality control of… [read post]
10 Nov 2008, 5:31 pm
In October 2007 The Agency Estimated It Would Need Up To 12 Months To Complete Investigation Regarding This Possible Bisphosphonate Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) The possible link between bisphosphonates such as Fosamax and the heart condition atrial fibrillation is the subject of an ongoing FDA safety review that should be finished, soon. [read post]
30 Jan 2007, 9:44 am
Continues To Be Pay Defense Lawyers, Not Plaintiffs, Taking Each Case To Trial (Posted by Tom Lamb at DrugInjuryWatch.com) Merck & Co., Inc.'s President and CEO Richard Clark reported to financial analysts during a January 30, 2007 Earnings Conference Call that the drug company has increased its legal reserves for the ongoing Vioxx litigation and new Fosamax lawsuits. [read post]
20 Oct 2011, 5:36 am
Here Is Why Aetna Wants To Know Whether You Have Filed A Gallbladder Or A Blood Clot Lawsuit Against Bayer (Posted by Tom Lamb at DrugInjuryWatch.com) We have learned that women who took the birth control pills YAZ, Yasmin, or Ocella while they had medical insurance from Aetna are receiving letters asking questions such as: Did you suffer any cardiovascular - or gallbladder - related injury or injuries during or after [the period when you used Yaz, Yasmin, or Ocella]? [read post]
Digitek Update December 2008: Actavis Contends No Defective Digitek Pills Were Ever Used By Patients
29 Dec 2008, 12:47 pm
At About Same Time, Drug Company Accepts FDA Consent Decree In Connection With Justice Department's Injunction Complaint (Posted by Tom Lamb at DrugInjuryWatch.com) In late December 2008 investigative reporter Jeanne Lenzer's hard-hitting article about the Digitek fiasco, "Did the FDA Miss Signals on a Troubled Heart Drug? [read post]
